Legend Biotech says CARVYKTI posts about $710 million net trade sales in quarter ended Sept. 30, 2026

Legend Biotech flagged preliminary CARVYKTI net trade sales of about $710 million for the quarter ended Sept. 30, 2026. Figure was provided by partner Janssen; Legend Biotech has not independently verified the amount. No percentage changes were disclosed in the update. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Legend Biotech Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001171843-26-006593), on October 13, 2026, and is solely responsible for the information contained therein. (C)